AstraZeneca PLC - Cambridge, UK-based pharmaceuticals firm - Announces wholly owned subsidiary AstraZeneca Finance prices a three tranche global bond offering totalling USD2.25 billion on February 28. Expects offering to close on March 3. Says the notes issued by AstraZeneca Finance LLC and fully and unconditionally guaranteed by AstraZeneca are USD1.1 billion of fixed rate notes with a coupon of 4.875%, maturing March 3 2028, USD650 million of fixed rate notes with a coupon of 4.900%, maturing March 3 2030, and USD500 million of fixed rate notes with a coupon of 4.875%, maturing March 3, 2033. Expects to use the net proceeds of the offering for general corporate purposes, which may include the refinancing of existing indebtedness.Current stock price: 10,815.57 pence12-month change: up 16%By Jeremy Cutler, Alliance News reporterComments and questions to newsroom@alliancenews.comCopyright 2023 Alliance News Ltd. All Rights Reserved